Company News

Burt’s Bees To Present Rosacea Data at AAD Meeting

Journal of Drugs in Dermatology publishes clinical data.

Author Image

By: Christine Esposito

Editor-in-Chief

Burt’s Bees reports that the Journal of Drugs in Dermatology has published clinical data supporting the efficacy and tolerability of its skin care products as an adjunct to rosacea prescription therapy. Abstracts outlining the study data will be shared at the American Academy of Dermatology Annual Meeting next month in Washington, D.C. The nature-based regimen clinically and statistically improved investigator-rated redness (erythema) by 28%; spider veins (telangiectasia) by 26% and pimple-li...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters